Status:
COMPLETED
Low-Cost Platelet-Rich Plasma for Hemarthropathy
Lead Sponsor:
University of Utah
Conditions:
Hemarthrosis
Hemophilia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Orthopedic complications can be injuries or diseases that affect the bones, muscles, and joints. Hemarthropathy is due to bleeding disorders, most commonly hemophilia, and can result in severe issues ...
Detailed Description
This study will be performed as a prospective, single arm study. Consecutive patients eligible for a standard-of-care injection will be enrolled from the Utah Center for Bleeding and Clotting Disorder...
Eligibility Criteria
Inclusion
- Patients of any adult age with symptomatic hemarthropathy of the ankle, knee, or elbow, based on radiographs within the last 24 months.
- Patients must have failed at least six weeks of conventional conservative treatments (such as medication or physical therapy).
Exclusion
- Exclusion criteria will include recent (last two years) surgery to the affected joint, prior joint replacement.
- Prior orthobiologic injection into the affected joint.
- Thrombocytopenia
- Inability to receive factor prior to PRP injection.
- Active systemic or local infection at the site of injection,
- Non-ambulatory patients
- Body mass index (BMI) over 50
- Recent (six month) or current corticosteroid injection/intake.
- Patients with hemarthropathy in multiple joints will be eligible for up to 2 joints if multiple fit the criteria.
Key Trial Info
Start Date :
July 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2025
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT06543368
Start Date
July 23 2024
End Date
May 5 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108